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ABSTRACTSon the endovascular database at 1, 3, and 12 months and annually there-
after. Changes in these measurements were calculated for each group.
Results: Palmaz stent-graft was used during 22 elective and 19 emergency
EVARs (17 elective and 10 emergency patients were included for analysis).
Throughout follow-up, the suprarenal diameter became greater in the
elective group (4.655.51mm vs. 2.24.13mm;p¼0.30) as were the top
neck (5.065.24mm vs. 4.66.02mm;p¼0.76) and bottom neck diameters
(5.946.53 vs. 3.114.26mm;p¼0.34). Aortic sac regression was higher in
emergency patients at 12 months (3.7121.03mm vs. 3.797.02mm;
p¼0.82) and at 24 months (1313.29mm vs. 4.369.61mm;p¼0.23). Open
re-intervention occurred in 20% of emergency patients for proximal type 1
endoleaks, with another 20% for stent-graft migrations. Re-intervention in
elective patients (18%) was for persistent type 2 endoleaks.
Conclusions: The complication rates, particularly in emergencies show
that Palmaz stenting provides only a short-term solution in EVAR. This
should inﬂuence patient selection as secondary procedures are more
likely.
0603: PERSISTENT SCIATIC ARTERY ANEURYSM: A PLEA FOR ATTEN-
TION AND PROPOSAL FOR MANAGEMENT
Nigel Day 1, Andrew Currie 1, Keith Jones 2. 1Kingston Hospital, London, UK;
2 St George's Hospital, London, UK.
Aim: This article reviewed published evidence on the identiﬁcation and
management of persistent sciatic artery aneurysms.
Methods: Systematic literature review was undertaken using Medline,
EMBASE and Cochrane Database of Systematic Reviews up to December
31st 2012. A free text search using “persistent sciatic artery”, “persistent
sciatic artery aneurysm”, “complete PSA” and “incomplete PSA” was per-
formed. All papers identiﬁed were screened and the search enhanced with
manual bibliography review.
Results: 49 relevant studies were identiﬁed. PSA has an incidence of
0.025%-0.04%. PSA aneurysms, though usually asymptomatic, may present
with a gluteal mass or distal embolization and ischaemia. Investigation is
most commonly performed by angiography, although non-invasive
methods show surgical planning advantages. Management is guided by
anatomical determination of the complete or incomplete forms. For the
complete forms, where the PSA supplies distal limb blood supply, this
entails exclusion of the aneurysm and vascular reconstruction with open
or endovascular techniques. Incomplete forms, where the PSA is present
with intact normal circulation, normally require simple aneurysmal
exclusion only.
Conclusion: Vascular specialists should be aware of this rare, often
asymptomatic vascular anomaly as it can complicate common vascular
emergencies. Timely surgical or endovascular interventions are vital due to
the high risk of aneurysmal dilatation.
0630: ASSESSING THE QUALITY OF ONLINE INFORMATION FOR PA-
TIENTS WITH CAROTID DISEASE
Cillian J. Keogh 1, Seamus M. McHugh 2, Mary Clarke-Moloney 2,
Paul E. Burke 2, Eamon G. Kavanagh 2, Pierce A. Grace 2,
Stewart R. Walsh 1. 1Graduate Entry Medical School, University of Limerick,
Limerick, Ireland; 2Department of Vascular Surgery, University Hospital
Limerick, Dooradoyle, Limerick, Ireland.
Aim: Controversy exists relating to carotid endarterectomy (CEA) versus
carotid artery stenting (CAS). We aimed to assess the quality of online
information relating to both.
Methods: The GoogleTM search engine was searched for “carotid endar-
terectomy” and “carotid stenting”. The ﬁrst 50 webpages returned were
assessed. The Gunning Fog Index (GFI) and Flesch Reading Ease Score
(FRES) were calculated to assess readability. The LIDA tool (Minervation
Ltd., Oxford, U.K.) was used to assess accessibility, usability and reliability.
Results: Regarding CEA, 20% (n¼10) of the webpages returned were from
peer reviewed sources with 34% (n¼17) posted by hospitals or health
services. Comparatively, for CAS, 40% (n¼20) were peer reviewed with 16%
(n¼8) posted by hospitals or health services. Regarding CEA, the GFI
and FRES indicated poor readability at 14.84 and 42.38 respectively. For
CAS web page assessment suggested further reduced readability with a GFI
of 15.91 and FRES score of 36.01. The LIDA score demonstrated that reli-
ability and accessibility of informationwas greater than usability for online
users.Conclusion: Websites providing information on carotid disease manage-
ment must be made more readable, reliable and usable. Online informa-
tion currently available to patients regarding CAS is signiﬁcantly more
difﬁcult to read and comprehend than CEA.
0653: REVIEW OF POST-OPERATIVE ANTICOAGULATION IN THE SURGI-
CAL MANAGEMENT OF ARTERIAL EMBOLIC DISEASE
Martha Nixon, Marcos Kostalas, Keith Gomes-Pinto, John Taylor,
David Williams. Northern Devon Healthcare NHS Trust, Barnstaple, UK.
Introduction: There is no guidance on post-operative anticoagulation af-
ter embolectomy. The purpose of this study was to review the use and
outcomes of low molecular weight heparin (LMWH) and unfractionated
heparin (UFH) following embolectomy.
Methods: Retrospective case review of patients undergoing embolectomy
from December 2009 - December 2012 was performed.
Results: 33 patients were included. 20 femoral, 5 brachial, 4 popliteal, 2
iliac and 2 graft embolectomies were performed. Anticoagulation prior to
surgery included heparin (n¼16, 48%), clexane (n¼4, 12%), or nothing
(n¼13, 39%). Intra-operatively heparin (n¼ 24, 73%) or nothing (n¼9, 27%)
was given. Post-operatively LMWH (n¼20, 61%), heparin (n¼9, 27%),
aspirin/clopidogrel (n¼3, 9%) or nothing (n¼1, 3%) was given. Patients
were discharged on warfarin (n¼21, 64%), aspirin (n¼5, 15%), clopidogrel
(n¼2, 3%), clexane (n¼3, 9%), rivaroxaban (n¼1, 3%) or nothing (n¼1, 3%).
The overall complication rate was 33% (including haematoma, wound
infection, amputation, claudication and death), 67% for those on heparin
post-operatively compared to 25% on clexane. Mortality was 30% with
average time to death of 9½ months.
Conclusion: This study has shown that clexane is a suitable and possibly
superior alternative to UFH. The authors have been surprised by the
mortality in this group of patients.
0681: ARE REFERRAL DELAYS CONTRIBUTING TO LIMB LOSS IN DIA-
BETIC PATIENTS?
Prashant Menon 2, Jenan Younis 2, M. Clarke 1, Alex Wee 1,
Emma Bingham1, Patrick Chong 2. 1Multidisciplinary Diabetic Foot Service
Frimley Park Hospital NHS Foundation Trust, Frimley, UK; 2Department of
Vascular Surgery Frimley Park Hospital NHS Foundation Trust, Frimley, UK.
A root cause analysis (RCA) was performed for major amputations (MA) in
diabetic patients to identify preventable causes for limb loss.
Data was collected retrospectively using HES codes for Diabetes and MA
(above knee/through knee/below knee) and analysed using the London
Diabetes Network RCA tool for MA.
20 diabetic patients underwentMA between 1st April 2010 and 31st March
2012. Median time from initial onset of symptoms (IOS) to any secondary
care review was 12 weeks while median time from IOS to diabetic foot
multidisciplinary team (DFMDT) review was 17 weeks. 6 patients (30%)
had no DFMDT clinic review before MA. 16 patients (80%) underwent in-
patient vascular imaging. Median interval from admission to vascular
imaging was 1 day (1-64). 10 patients (50%) underwent revascularisation
(Endovascular therapy n¼4 / Surgical bypass n¼3 / Endovascular Therapy
and Surgical Bypass n¼3) Median time from IOS to revascularisation was
70 days (2-1080) and median time from hospitalisation to revascularisa-
tion was 1 day (1-64). The 30-day post-MA mortality was 15%.
Our RCA highlights signiﬁcant delays in referral to the DFMDT in this
cohort with adverse limb salvage outcomes. The need to refer promptly to
the DFMDT should be stressed to carers in the community.
0781: PATIENT REPORTED OUTCOMES FOLLOWING CRITICAL
ISCHAEMIA MANAGEMENT IN THE REGIONAL VASCULAR CENTRE
Anna Kamocka, Ahmed Twaij, Oneet Sandher, Charlotte Ashton,
Jawaharlal Senaratne, Thomas Rix. Kent and Canterbury Hospital, East Kent
Hospitals Trust, Canterbury, Kent, UK.
Aims: Patient Reported Outcome Measures(PROMs) assess the health gain
after surgical intervention. Guided by existing PROMs assessments, we
designed a survey to review patient satisfaction following treatment of
critical limb ischaemia (CLI) at East Kent Hospitals Trust(EKHT).
Methods: All patients who underwent treatment for CLI between
November 2010 andMay 2011 were invited to ﬁll in an 11-question Patient
Satisfaction Survey, either by post or over the phone. Fisher's test was used
for statistical analysis.
